Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

3.23
Delayed Data
As of Jan 18
 -0.021 / -0.65%
Today’s Change
2.88
Today|||52-Week Range
10.87
+1.29%
Year-to-Date
SECTOR
Distribution Services
INDUSTRY
Wholesale Distributors
MARKET CAP
$33.9M

Company Description

DelMar Pharmaceuticals, Inc. is a clinical and commercial stage drug development company, which focuses on the research and development of drugs for the treatment of cancer. It offers VAL-083; drug discovery research; as well as patents and intellectual property. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in Vancouver, Canada.

Contact Information

DelMar Pharmaceuticals, Inc.
999 West Broadway
Vancouver British Columbia V5Z 1K5
P:(604) 629-5989
Investor Relations:

Employees

Shareholders

Individual stakeholders8.23%
Other institutional1.65%
Mutual fund holders0.04%

Top Executives

Jeffrey A. BachaChairman, President & Chief Executive Officer
Scott PraillChief Financial & Principal Accounting Officer
Dennis M. BrownDirector & Chief Scientific Officer
Jenene D. ThomasDirector-Investor Relation